A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.

Tourian, Karen; Wang, Ying; Ii, Yoichi

Tourian, Karen; Wang, Ying; Ii, Yoichi.

Affiliation

Tourian K; Pfizer, Collegeville, Pennsylvania, USA.

Int Clin Psychopharmacol ; 28(4): 206-13, 2013 Jul.

Article in En | MEDLINE | ID: mdl-23587982

Subject(s)

Antidepressive Agents/adverse effects; Cyclohexanols/adverse effects; Depressive Disorder, Major/drug therapy; Neurotransmitter Uptake Inhibitors/adverse effects; Adult; Antidepressive Agents/administration & dosage; Antidepressive Agents/therapeutic use; Cyclohexanols/administration & dosage; Cyclohexanols/therapeutic use; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence/chemically induced; Disorders of Excessive Somnolence/epidemiology; Drug Monitoring; Female; Headache/chemically induced; Headache/epidemiology; Humans; Incidence; Intention to Treat Analysis; Japan/epidemiology; Male; Middle Aged; Nasopharyngitis/chemically induced; Nausea/chemically induced; Nausea/epidemiology; Neurotransmitter Uptake Inhibitors/administration & dosage; Neurotransmitter Uptake Inhibitors/therapeutic use; Psychiatric Status Rating Scales

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neurotransmitter Uptake Inhibitors / Cyclohexanols / Depressive Disorder, Major / Antidepressive Agents Type of study: Clinical_trials / Incidence_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2013 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google